Literature DB >> 28169962

Parkin mediates neuroprotection through activation of Notch1 signaling.

Ji-Hye Yoon1, Eun-Jung Ann, Mi-Yeon Kim, Ji-Seon Ahn, Eun-Hye Jo, Hye-Jin Lee, Hye-Won Lee, Young Chul Lee, Jeong-Sun Kim, Hee-Sae Park.   

Abstract

Parkin, an E3 ubiquitin ligase, is the most frequently mutated gene in hereditary Parkinson's disease. Inactivation of Parkin leads to impairment of the ubiquitin-proteasome system, resulting in the accumulation of misfolded or aggregated proteins and ensuing neurodegeneration. In this study, we show that Parkin positively regulates the Notch1 signaling pathway. Overexpression of Parkin stabilized Notch1-IC protein levels, whereas knockdown of Parkin decreased Notch1-IC protein stability. Notably, overexpression of Parkin disrupted oxidative stress-induced apoptosis in neuronal cells. However, knockdown of Notch1 inhibited Parkin-induced neuronal cell survival. Together, these results indicate that Parkin is a novel regulator of the Notch1 signaling pathway, which promotes neuronal cell survival.

Entities:  

Year:  2017        PMID: 28169962     DOI: 10.1097/WNR.0000000000000726

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Effect of the Notch signaling pathway on retinal ganglion cells and its neuroprotection in rats with acute ocular hypertension.

Authors:  Lei Li; Li-Ping Chen; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

2.  Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.

Authors:  Anna Santaella; H Bea Kuiperij; Anouke van Rumund; Rianne A J Esselink; Alain J van Gool; Bastiaan R Bloem; Marcel M Verbeek
Journal:  BMC Neurol       Date:  2020-01-17       Impact factor: 2.474

Review 3.  Mitophagy in Diabetic Kidney Disease.

Authors:  Xiaofeng Zhang; Jing Feng; Xia Li; Dan Wu; Qian Wang; Shuyu Li; Changhua Shi
Journal:  Front Cell Dev Biol       Date:  2021-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.